🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Mindfulness-based Relapse Prevention for Peer Workers

RecruitingNAAges 18 Years - 100 YearsAllUniversity of Texas at Austin
NCT07741825 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Adapt and test the effectiveness of MBRP for substance use peer workers compared to a standard of care (referral to 12-step) control condition on substance use, relapse risk, and burnout among peers in a pilot hybrid type 1 trial. The goal of this clinical trial is to learn if Mindfulness-Based Relapse Prevention can reduce substance use, relapse risk, and burnout among substance use peer workers. The objectives are to: 1. Identify the causes, consequences, and risk and protective factors for relapse among peer workers; 2. Identify peers' preferences related to MBRP content, structure, and delivery; 3. Adapt the MBRP intervention for peer workers; and 4. Assess the preliminary effectiveness and implementation outcomes of the adapted MBRP intervention. Researchers will compare MBRP to referral to 12-step (standard of care) to see if MRBP works to reduce substance use, relapse risk, and

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Are \> 18 years old 2. Fluent in English 3. Be currently employed in a substance use peer support role 4. At-risk for SUD relapse as measured by a craving score of \>15 on the adapted Penn Alcohol Craving Scale Exclusion Criteria: 1. Have a cognitive impairment that jeopardizes informed consent 2. Actively suicidal or psychotic
💊

What it tests

  • Mindfulness Based Relapse Prevention
  • Standard of Care
📍

Where

1 site
Addiction Research Institute
Austin, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy